Detalhe da pesquisa
1.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108470
2.
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(11): 1506-1517, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582355
3.
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.
Lancet Oncol
; 16(6): 729-36, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981813
4.
Chemotherapy ± cetuximab modulates peripheral immune responses in metastatic colorectal cancer.
Oncology
; 84(5): 273-83, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445638
5.
Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection.
BMC Cancer
; 12: 264, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22892134
6.
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).
Clin Cancer Res
; 28(15): 3277-3286, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294546
7.
Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report.
BMC Gastroenterol
; 11: 33, 2011 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21470434
8.
Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.
Emerg Infect Dis
; 15(6): 956-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19523302
9.
Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
BMC Cancer
; 9: 264, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19646258
10.
Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patients.
Mol Clin Oncol
; 5(4): 440-446, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699040
11.
Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer?
Expert Rev Anticancer Ther
; 14(2): 163-72, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24308686
12.
Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.
J Cancer Res Clin Oncol
; 139(12): 1995-2003, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072231
13.
Pregabalin for opioid-refractory pain in a patient with ankylosing spondylitis.
Case Rep Psychiatry
; 2013: 912409, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23844301
14.
DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.
Anticancer Res
; 33(3): 1209-14, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23482804
15.
Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy.
ISRN Gastroenterol
; 2013: 490578, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23840958
16.
Pituitary insufficiency after infectious meningitis: a prospective study.
J Clin Endocrinol Metab
; 95(7): 3277-81, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20427491
17.
Predictors of survival in stage IV metastatic colorectal cancer.
Anticancer Res
; 30(2): 653-60, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20332485
18.
Hypercalcemia in a patient with cholangiocarcinoma: a case report.
Int Arch Med
; 2(1): 35, 2009 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19878543